Global Contraceptive Drugs Market is Segmented By Type (Oral Contraceptive Pills, Topical Contraceptive Patch, Contraceptive Injectables), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Size
The global contraceptive drugs market reached USD 13.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 22.4 billion by 2031. The global contraceptive drugs market is expected to exhibit a CAGR of 6.6% during the forecast period (2024-2031). Contraception usage minimises the need for abortion by avoiding undesired pregnancies. As a result, it minimises incidences of unsafe abortion, which is one of the main causes of maternal mortality globally.
Contraception is critical in lowering mother and infant mortality rates. When pregnancies are planned and spaced adequately, women may get adequate prenatal care, improving their health and the health outcomes for their newborns.
Furthermore, the contraceptive drugs market is driven by various factors like the growth in focus on the need for family planning and preventing unwanted pregnancy, the increase in the use of contraception in young women along with the rise in higher educational attainment propels the market growth.
Market Scope
| Metrics | Details |
| CAGR | 6.6% |
| Size Available for Years | 2022-2031 |
| Forecast Period | 2024-2031 |
| Data Availability | Value (US$) |
| Segments Covered | Type, Distribution Channel, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Infection Type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
To Know More Insights - Download Sample
Market Dynamics
Increase R&D Activities
The market is flourishing due to increased R&D activities, introducing various treatment options and research to combat unwanted pregnancy. Clinical trials will be helpful in introducing new contraceptive pills and gels, addressing new laws and limitations on current birth control procedures. Research is also focused on developing a non-hormonal pill to expand men's birth control options.
For instance, according to clinical trail.gov on December 21 2022, Copenhagen University hospital, Rigshospitalet, Denmark started a clinical studies on The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling with around 40 patients enrollment where the study is estimated to complete by Aug 2025.
Rising Prevalence Of Sexually Transmitted Diseases (STD) Coupled With Favourable Initiatives
The global rise in sexually transmitted diseases (STD) is expected to boost market demand for contraceptives, including pills, patches, and rings. The World Health Organization (WHO) is working to improve contraceptive services and prevent infections, while government and non-government organizations are investing in increasing awareness and focusing on sexual health.
For instance, according to WHO updated factsheet, over 1 million STIs are acquired daily globally, with 374 million new infections each year. Over 500 million people 15-49 years old have genital HSV or herpes simplex virus infections, and HPV infection is linked to over 311 000 cervical cancer deaths annually. In 2016, syphilis infected 1 million pregnant women, resulting in over 350,000 adverse birth outcomes.
Side Effects Associated With Contraceptives Pills
The most common adverse effect of combined oral contraceptive pills is breakthrough bleeding. Women will also complain of nausea, headaches, abdominal cramping, breast tenderness, and increased vaginal discharge or decreased libido. Nausea can be avoided by taking the medication at night before sleep.
Market Segment Analysis
The global contraceptive drugs market is segmented based on type , distribution channel and region.
Oral Contraceptive Pills From By Type Segment Accounted for Approximately 46.3% of the Contraceptives Mrket Share
The oral contraceptive pills from by type segment with around 46.3% of market share during the forecast period. Oral Contraceptive Pills, also known as birth control pills, are hormones that block egg release from the ovaries. When used correctly and consistently, they prevent unintended pregnancies and offer a reliable, reversible method of contraception, allowing individuals to control their reproductive choices.
For instance,in Oct 2022 Gedeon Richter UK Ltd. has announced the availability of Drovelis as a combined oral contraceptive in the UK. The decision to prescribe E4/DRSP should consider individual women's risk factors, especially those for venous thromboembolism. This comes a year after the Medicines and Healthcare products Regulatory Agency granted a UK license for E4/DRSP.
Global Contraceptive Drugs Market Geographical Share
North America Accounted for Approximately 37.6% of the Market Share in 2022,
North America is estimated to hold about 37.6% of the total market share throughout the forecast period because of favourable FDA approvals, government programmes, a high number of undesired pregnancies, an increase in the frequency of sexually transmitted infections, and other factors, For instance, in July 2022 Perrigo Company plc , a leading global provider of Consumer Self-Care Products, announced that HRA Pharma, a Perrigo company, has submitted an application to the US Food and Drug Administration (FDA) for the first-ever OTC birth control pill in the US.
Market Companies
The major global players in the contraceptives drugs include Church & Dwight Co Inc, Teva Pharmaceuticals, Merck & Co Inc, Agile Therapeutics, Ansell Ltd, Mayer Laboratories Inc, Veru Inc, Pfizer Inc, Bayer AG, Abbvie Inc and others.
COVID-19 Impact on Contraceptive Drugs Market
COVID-19 has had a substantial influence on the value of the contraceptive market. During the pandemic, the use of innovative techniques and technology, including as the use of telemedicine and telehealth in contraceptive start and maintenance, became the standard of care. Numerous telehealth methods allow individuals to connect with health care providers via technology. Supporting mobile outreach programmes that distribute a wide choice of contraceptive products in locations where healthcare practitioners are few has boosted the industry's value.
Russia Ukraine Conflict Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global contraceptives owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global contraceptive drugs market growth over the forecast period.
By Type
- Oral Contraceptive Pills
- Topical Contraceptive Patch
- Contraceptive Injectable
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
- In March 2021, Cooper completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth.
- In November 2022 Liletta has been approved for pregnancy prevention for up to 8 years, based on efficacy data from the ACCESS IUS trial. The trial evaluated Liletta in women aged 16 to 45, with the primary endpoint being the pregnancy rate calculated as the Pearl Index (PI).
Why Purchase the Report?
- To visualize the global contraceptive drugs market segmentation based on type, distribution channel and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of contraceptive drugs market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global contraceptives drugs report would provide approximately 53 tables, 54 figures and 195 pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
